Coronavirus and SARS-CoV-2 ELISA kits, GSD NovaLisa®
Supplier: GOLD STANDARD DIAGNOSTICS
Ratings:
(No Reviews)
Total Ratings: 0
Avg. Ratings: 0.0 out of 5
CVGQ0970
GSDCCVGQ0970EA
609
GBP
GSDCCVGQ0970
Coronavirus and SARS-CoV-2 ELISA kits, GSD NovaLisa®
Clinical Diagnostic Supplies
Clinical Reagents and Kits
Immunoassay for the quantitative and qualitative detection of specific IgG-class antibodies to the spike protein of SARS-CoV-2.
- Quantitative determination of antibodies to the SARS-CoV-2 spike (S) protein
- Trimeric SARS-CoV-2 Spike antigen
- Intended as an aid to evaluate patients immune status and determine vaccine efficacy
- Calibrators correlate to First WHO International Standards for SARS-CoV-2
- Diagnostic sensitivity and specificity of 99.94% and 99.49% respectively
- Validated for serum, plasma, and finger prick (serum from capillary blood) samples
It is intended to aid in the diagnosis of patients suspected of having COVID-19 disease or asymptomatic presentation of SARS-CoV-2, to monitor antibody levels during and after a COVID-19 infection, and to determine antibody levels before and after a COVID-19 vaccination.
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...